Chipscreen Biosciences
China - Shenzhen
BiotechnologyFocus: Cancer therapies
Chipscreen Biosciences is a life sciences company focused on Cancer therapies.
OncologyCell Therapy
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Chiauranib
Small Cell Lung CancerClinical Trials (1)
NCT05371899Mass Balance Study of [14C]Chiauranib
N/Achidamide and azacitidine
AML, AdultClinical Trials (1)
NCT06066905A Study of Chidamide With AZA in MRD Positive AML After Transplant
N/Atreatment T
T2DM (Type 2 Diabetes Mellitus)Clinical Trials (1)
NCT07412015Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets
N/ACS23546
Advanced TumorsClinical Trials (1)
NCT06245122A Study of CS23546 in Subjects With Advanced Tumors
Phase 1Chiauranib
Healthy VolunteersClinical Trials (1)
NCT05346601Trial of Chiauranib Capsule on Pharmacokinetics to Assess the Effect of High Fat Diet in Healthy Volunteers
Phase 1NWY001
Advanced Solid TumorClinical Trials (1)
NCT05979155A Study of NWY001 in Subjects With Advanced Solid Tumors
Phase 1Chiglitazar
T2DMClinical Trials (1)
NCT05681273Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.
Phase 1Chidamide
Peripheral T-cell LymphomaClinical Trials (1)
NCT02809573Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients
Phase 1Chiglitazar
Renal ImpairmentClinical Trials (1)
NCT05515458Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function
Phase 1Chiauranib
Non-Hodgkin's LymphomaClinical Trials (1)
NCT03074825Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma
Phase 1CS32582 capsule
HealthyClinical Trials (1)
NCT06224595A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic Profiles and Food Effect of CS32582 Capsules
Phase 1CS231295
NeoplasmsClinical Trials (1)
NCT06902350Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
Phase 1Chiauranib
Small Cell Lung CancerClinical Trials (1)
NCT03216343Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer
Phase 1CS12192 capsule
HealthyClinical Trials (1)
NCT05922709A Clinical Trial of CS12192 in Healthy Subjects
Phase 1Chiauranib
Solid TumorsClinical Trials (1)
NCT02122809Phase I Study of Chiauranib in Patients With Advanced Solid Tumors
Phase 1Chiglitazar
Hepatic ImpairmentClinical Trials (1)
NCT05515445Pharmacokinetics of Chiglitazar in Subjects With Hepatic Impairment and Normal Hepatic Function
Phase 1Chiauranib
Non-hodgkin's LymphomaClinical Trials (1)
NCT03974243Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma
Phase 1/2Chiauranib
Hepatocellular CarcinomaClinical Trials (1)
NCT03245190Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma
Phase 1/2CS32582 capsule（low dose） or matched placebo
Plaque PsoriasisClinical Trials (1)
NCT07129382A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
Phase 1/2Chiauranib
Small Cell Lung CancerClinical Trials (1)
NCT05271292Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
Phase 1/2AK104 IV infusionï¼›Chiauranib oral
SCLC,Extensive StageClinical Trials (1)
NCT05505825A Study of AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer
Phase 1/2Chiauranib
Ovarian CancerClinical Trials (1)
NCT03166891Phase Ib Study of Chiauranib in Patients With Ovarian Cancer
Phase 1/2Chidamide
Chronic HIV InfectionsClinical Trials (1)
NCT02513901Chidamide in Combination With Antiretroviral Therapy for Eradication of the Latent HIV-1 Reservoir
Phase 1/2Chiglitazar Placebo
MASH - Metabolic Dysfunction-Associated SteatohepatitisClinical Trials (1)
NCT07303803A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus
Phase 2Chiauranib
Soft Tissue SarcomaClinical Trials (1)
NCT05497843Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)
Phase 2Chidamide
Non Small Cell Lung CancerClinical Trials (1)
NCT05068427Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.
Phase 2chidamide
Multiple MyelomaClinical Trials (1)
NCT03605056Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MM
Phase 2Venetoclax Combining Chidamide and Azacitidine
Leukemia, Myeloid, AcuteClinical Trials (1)
NCT05603884VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Phase 2Chiauranib
Triple-negative Breast CancerClinical Trials (1)
NCT05336721A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC
Phase 2Chiauranib
Pancreatic Ductal AdenocarcinomaClinical Trials (1)
NCT06492915Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Phase 2Anti-PD-1 Antibody Plus Chidamide and Rituximab
Relapsed or Refractory DLBCLClinical Trials (1)
NCT05115409Anti-PD-1 Antibody Plus Chidamide and Rituximab Regimen in Relapsed or Refractory DLBCL (PCR)
Phase 2chiauranib
Ovarian CancerClinical Trials (1)
NCT03901118Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer
Phase 2Chidamide
Non-small-cell Lung CancerClinical Trials (1)
NCT01836679Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer
Phase 2chiglitazar sodium tablets
NASHClinical Trials (1)
NCT05193916A Phase II Clinical Trial of Chiglitazar for NASH
Phase 2Tucidinostat
Non Small Cell Lung CancerClinical Trials (1)
NCT05519865A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC
Phase 2ART plus Chidamide
Chronic HIV InfectionsClinical Trials (1)
NCT02902185Chidamide in Combination With ART for Reactivation of the Latent HIV-1 Reservoir
Phase 2/3Phase 3
Clinical Trials (1)
NCT07445295Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Phase 3Chiglitazar 32mg
Type 2 DiabetesClinical Trials (1)
NCT04807348Chiglitazar Added to Metformin for Type 2 Diabetes
Phase 3Phase 3
Clinical Trials (1)
NCT06947967Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
Phase 3Phase 3
Clinical Trials (1)
NCT04231448Phase III Study of Tucidinostat in Combination With R-CHOP in Patients With Newly Diagnosed Double-Expressor DLBCL
Phase 3chiauranib
Ovarian CancerClinical Trials (1)
NCT04921527Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
Phase 3Tucidinostat
Colorectal CancerClinical Trials (1)
NCT06497985A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
Phase 3Chiglitazar
Type 2 DiabetesClinical Trials (1)
NCT02173457Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients
Phase 3Chidamide
Breast CancerClinical Trials (1)
NCT02482753Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Phase 3Chiauranib
Small Cell Lung CancerClinical Trials (1)
NCT04830813Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer
Phase 3Chiglitazar
Type 2 DiabetesClinical Trials (1)
NCT02121717Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2016
Portfolio: 46 clinical trials